135 related articles for article (PubMed ID: 31506480)
1. Non-invasive Potential Circulating mRNA Markers for Colorectal Adenoma Using Targeted Sequencing.
Xue VW; Cheung MT; Chan PT; Luk LLY; Lee VH; Au TC; Yu AC; Cho WCS; Tsang HFA; Chan AK; Wong SCC
Sci Rep; 2019 Sep; 9(1):12943. PubMed ID: 31506480
[TBL] [Abstract][Full Text] [Related]
2. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B
Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150
[TBL] [Abstract][Full Text] [Related]
4. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
5. Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing.
LaPointe LC; Pedersen SK; Dunne R; Brown GS; Pimlott L; Gaur S; McEvoy A; Thomas M; Wattchow D; Molloy PL; Young GP
PLoS One; 2012; 7(1):e29059. PubMed ID: 22276102
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of m
Kuai D; Zhu S; Shi H; Yang R; Liu T; Liu H; Min L; Zhang S
Life Sci; 2021 May; 273():119258. PubMed ID: 33636176
[TBL] [Abstract][Full Text] [Related]
7. Discovery and Validation of Circulating Biomarkers of Colorectal Adenoma by High-Depth Small RNA Sequencing.
Roberts BS; Hardigan AA; Moore DE; Ramaker RC; Jones AL; Fitz-Gerald MB; Cooper GM; Wilcox CM; Kimberly RP; Myers RM
Clin Cancer Res; 2018 May; 24(9):2092-2099. PubMed ID: 29490987
[No Abstract] [Full Text] [Related]
8. Relationship between tumor and peripheral blood NPRL2 mRNA levels in patients with colorectal adenoma and colorectal cancer.
Liu AY; Liu DG; Du YJ; Pei FH; Yang G; Liu BR; Zhang HT; Wang XH; Fan YJ; Chen YZ; Jiang Y; Chen J
Cancer Biol Ther; 2014 May; 15(5):489-95. PubMed ID: 24521741
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
[TBL] [Abstract][Full Text] [Related]
10. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
[TBL] [Abstract][Full Text] [Related]
11. Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes.
Galamb O; Sipos F; Spisák S; Galamb B; Krenács T; Valcz G; Tulassay Z; Molnár B
Cell Oncol; 2009; 31(1):19-29. PubMed ID: 19096147
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic mRNA expression patterns of inflamed, benign, and malignant colorectal biopsy specimen and their correlation with peripheral blood results.
Galamb O; Sipos F; Solymosi N; Spisák S; Krenács T; Tóth K; Tulassay Z; Molnár B
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2835-45. PubMed ID: 18843029
[TBL] [Abstract][Full Text] [Related]
13. RNA-sequencing identification and validation of genes differentially expressed in high-risk adenoma, advanced colorectal cancer, and normal controls.
Kim N; Gim JA; Lee BJ; Choi BI; Park SB; Yoon HS; Kang SH; Kim SH; Joo MK; Park JJ; Kim C; Kim HK
Funct Integr Genomics; 2021 Jul; 21(3-4):513-521. PubMed ID: 34273035
[TBL] [Abstract][Full Text] [Related]
14. Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection.
Rodia MT; Ugolini G; Mattei G; Montroni I; Zattoni D; Ghignone F; Veronese G; Marisi G; Lauriola M; Strippoli P; Solmi R
Oncotarget; 2016 May; 7(21):30295-306. PubMed ID: 26993598
[TBL] [Abstract][Full Text] [Related]
15. The roles of JK-1 (FAM134B) expressions in colorectal cancer.
Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK
Exp Cell Res; 2014 Aug; 326(1):166-73. PubMed ID: 24973512
[TBL] [Abstract][Full Text] [Related]
16. Exosomes in colorectal carcinoma formation: ALIX under the magnifying glass.
Valcz G; Galamb O; Krenács T; Spisák S; Kalmár A; Patai ÁV; Wichmann B; Dede K; Tulassay Z; Molnár B
Mod Pathol; 2016 Aug; 29(8):928-38. PubMed ID: 27150162
[TBL] [Abstract][Full Text] [Related]
17. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
Luo X; Wu Y; Ji M; Zhang S
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
[TBL] [Abstract][Full Text] [Related]
18. Quantification of plasma beta-catenin mRNA in colorectal cancer and adenoma patients.
Wong SC; Lo SF; Cheung MT; Ng KO; Tse CW; Lai BS; Lee KC; Lo YM
Clin Cancer Res; 2004 Mar; 10(5):1613-7. PubMed ID: 15014011
[TBL] [Abstract][Full Text] [Related]
19. Cell-surface markers for colon adenoma and adenocarcinoma.
Sewda K; Coppola D; Enkemann S; Yue B; Kim J; Lopez AS; Wojtkowiak JW; Stark VE; Morse B; Shibata D; Vignesh S; Morse DL
Oncotarget; 2016 Apr; 7(14):17773-89. PubMed ID: 26894861
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of multiple genes involved in retinoic acid biosynthesis in human colorectal cancer.
Kropotova ES; Zinovieva OL; Zyryanova AF; Dybovaya VI; Prasolov VS; Beresten SF; Oparina NY; Mashkova TD
Pathol Oncol Res; 2014 Jul; 20(3):707-17. PubMed ID: 24599561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
